Stevens Capital Management’s Core Laboratories CLB Stock Holding History

Stevens Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-21,381	Closed	-$1.12M	–	576
2019 Q2	$1.12M	Buy	+21,381	New	+$1.25M	0.05%	347
2019 Q1	–	Sell	-12,431	Closed	-$742K	–	709
2018 Q4	$742K	Buy	+12,431	New	+$1.07M	0.04%	437
2018 Q3	–	Sell	-7,094	Closed	-$895K	–	753
2018 Q2	$895K	Sell	7,094 -10,948	-61%	-$1.33M	0.03%	453
2018 Q1	$1.95M	Buy	+18,042	New	+$2M	0.07%	292
2017 Q4	–	Sell	-19,699	Closed	-$1.94M	–	852
2017 Q3	$1.94M	Buy	+19,699	New	+$1.91M	0.07%	315
2016 Q4	–	Sell	-20,775	Closed	-$2.33M	–	900
2016 Q3	$2.33M	Buy	20,775 +4,422	+27%	+$509K	0.1%	254
2016 Q2	$2.03M	Buy	+16,353	New	+$1.97M	0.08%	297
2015 Q3	–	Sell	-4,532	Closed	-$517K	–	1003
2015 Q2	$517K	Buy	+4,532	New	+$550K	0.02%	608
2014 Q3	–	Sell	-6,964	Closed	-$1.16M	–	1026
2014 Q2	$1.16M	Buy	+6,964	New	+$1.24M	0.03%	473

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Stevens Capital Management's CLB Position: Q3 2019 in Review

Stevens Capital Management sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 21,381 shares — an estimated $1.12M sold.

Stevens Capital Management first reported a position in CLB in Q2 2014 and held it in 9 quarters. The position peaked at $2.33M in Q3 2016. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Stevens Capital Management reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
Stevens Capital Management sold 21,381 Core Laboratories shares in Q3 2019, an estimated $1.12M.
Stevens Capital Management first reported a position in Core Laboratories in Q2 2014 and held it in 9 quarters.
Stevens Capital Management's Core Laboratories position peaked at $2.33M in Q3 2016.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Stevens Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.